Precigen (PGEN) News Today $1.71 -0.11 (-6.04%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$1.74 +0.03 (+1.75%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Cantor Fitzgerald Comments on Precigen FY2025 EarningsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Precigen in a research report issued on Thursday, March 20th. Cantor Fitzgerald analyst J. Kim anticipates that the biotechnology company will post earnings peMarch 24 at 2:03 AM | marketbeat.comHC Wainwright Has Negative Forecast for Precigen Q1 EarningsMarch 24 at 1:13 AM | americanbankingnews.comHC Wainwright Has Negative Estimate for Precigen Q1 EarningsPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Stock analysts at HC Wainwright cut their Q1 2025 earnings per share estimates for shares of Precigen in a research report issued to clients and investors on Thursday, March 20th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology coMarch 24 at 1:12 AM | marketbeat.comHC Wainwright Issues Negative Forecast for Precigen EarningsMarch 23 at 3:33 AM | americanbankingnews.comPrecigen (NASDAQ:PGEN) Stock Price Up 6.9% - What's Next?Precigen (NASDAQ:PGEN) Trading 6.9% Higher - What's Next?March 22, 2025 | marketbeat.comFY2027 EPS Estimates for Precigen Decreased by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Equities researchers at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Precigen in a report released on Thursday, March 20th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology company will post earnings of $March 22, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Precigen (NASDAQ:PGEN)HC Wainwright reiterated a "buy" rating and issued a $6.00 price objective on shares of Precigen in a report on Thursday.March 21, 2025 | marketbeat.comPrecigen options imply 20.1% move in share price post-earningsMarch 20, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Edwards Lifesciences (EW)March 20, 2025 | markets.businessinsider.com4PGEN : Expert Outlook: Precigen Through The Eyes Of 4 AnalystsMarch 20, 2025 | benzinga.comPrecigen (NASDAQ:PGEN) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPSPrecigen (NASDAQ:PGEN - Get Free Report) posted its quarterly earnings results on Wednesday. The biotechnology company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.02. Precigen had a negative net margin of 3,521.68% and a negative return on equity of 123.06%.March 20, 2025 | marketbeat.comPrecigen, Inc.: Precigen Reports Full Year 2024 Financial Results and Business UpdatesMarch 20, 2025 | finanznachrichten.dePrecigen Reports Progress and Financial Results for 2024March 19, 2025 | tipranks.comPrecigen, Inc. (PGEN) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comPrecigen Reports Full Year 2024 Financial Results and Business UpdatesMarch 19, 2025 | prnewswire.comPrecigen (NASDAQ:PGEN) Shares Down 4.2% - Here's WhyPrecigen (NASDAQ:PGEN) Shares Down 4.2% - Time to Sell?March 18, 2025 | marketbeat.comPrecigen (PGEN) to Release Quarterly Earnings on WednesdayMarch 17, 2025 | americanbankingnews.comPrecigen, Inc. (NASDAQ:PGEN) Receives $7.00 Average PT from BrokeragesMarch 16, 2025 | americanbankingnews.comPrecigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19thMarch 13, 2025 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five brokerages that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and four have issued a buy ratinMarch 11, 2025 | marketbeat.comPrecigen (PGEN) Projected to Post Earnings on TuesdayPrecigen (NASDAQ:PGEN) will be releasing earnings before the market opens on Tuesday, March 18, Financial Modeling Prep reports.March 11, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Shares Up 7.7% - Time to Buy?Precigen (NASDAQ:PGEN) Shares Up 7.7% - What's Next?February 28, 2025 | marketbeat.comPrecigen: UltraCAR-T Development Brings Another Side Of Pipeline AdvancementFebruary 28, 2025 | seekingalpha.comPrecigen shares surge on FDA priority review for PRGN-2012February 25, 2025 | in.investing.comPrecigen (NASDAQ:PGEN) Shares Gap Up - What's Next?Precigen (NASDAQ:PGEN) Shares Gap Up - Time to Buy?February 25, 2025 | marketbeat.comPrecigen’s BLA for PRGN-2012 in papillomatosis granted priority review by FDAFebruary 25, 2025 | markets.businessinsider.comFDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025February 25, 2025 | prnewswire.comPrecigen (NASDAQ:PGEN) Hits New 1-Year High - Here's WhyPrecigen (NASDAQ:PGEN) Hits New 52-Week High - Should You Buy?February 20, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading 8.4% Higher - Here's What HappenedPrecigen (NASDAQ:PGEN) Shares Up 8.4% - Should You Buy?February 19, 2025 | marketbeat.comAnalysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $7.00Shares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five brokerages that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and four have given a buy recommeFebruary 17, 2025 | marketbeat.comPGEN Stock Soars to 52-Week High, Reaching $1.93 Amid GrowthFebruary 13, 2025 | msn.comPrecigen (NASDAQ:PGEN) Sets New 52-Week High - Still a Buy?Precigen (NASDAQ:PGEN) Sets New 52-Week High - Here's What HappenedFebruary 12, 2025 | marketbeat.comPrecigen: Successful Proof Of Platform, But Cash Worries RemainFebruary 10, 2025 | seekingalpha.comPrecigen (NASDAQ:PGEN) Stock Price Up 7.8% - Time to Buy?Precigen (NASDAQ:PGEN) Trading 7.8% Higher - Should You Buy?February 7, 2025 | marketbeat.comIridian Asset Management LLC CT Purchases 1,465,962 Shares of Precigen, Inc. (NASDAQ:PGEN)Iridian Asset Management LLC CT increased its position in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 38.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,241,922 shares of the biotechnology company's stock after purchasing an addiFebruary 7, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN)JPMorgan Chase & Co. decreased its holdings in Precigen, Inc. (NASDAQ:PGEN - Free Report) by 18.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 884,275 shares of the biotechnology company's stock after selling 194,514 shares during the quJanuary 27, 2025 | marketbeat.comFY2024 EPS Estimates for Precigen Lifted by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - HC Wainwright upped their FY2024 EPS estimates for shares of Precigen in a research note issued on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will earn ($0.30) per share for the year, up from tJanuary 27, 2025 | marketbeat.comPrecigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012January 24, 2025 | msn.comLexAurum Advisors LLC Increases Stock Position in Precigen, Inc. (NASDAQ:PGEN)LexAurum Advisors LLC grew its position in shares of Precigen, Inc. (NASDAQ:PGEN - Free Report) by 151.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 691,544 shares of the biotechnology company's stock after purchasing an additional 41January 24, 2025 | marketbeat.comFY2026 EPS Estimates for Precigen Decreased by HC WainwrightPrecigen, Inc. (NASDAQ:PGEN - Free Report) - Research analysts at HC Wainwright cut their FY2026 EPS estimates for shares of Precigen in a note issued to investors on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will earn ($0.01) per shJanuary 24, 2025 | marketbeat.comPrecigen price target raised to $6 from $4 at H.C. WainwrightJanuary 23, 2025 | markets.businessinsider.comInvestors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN)Precigen, Inc. (NASDAQ:PGEN - Get Free Report) was the target of some unusual options trading activity on Thursday. Investors acquired 11,169 call options on the stock. This is an increase of approximately 1,645% compared to the average volume of 640 call options.January 23, 2025 | marketbeat.comPrecigen's (PGEN) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $6.00 price target (up from $4.00) on shares of Precigen in a report on Thursday.January 23, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the five research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation and four have issuedJanuary 20, 2025 | marketbeat.comPrecigen shares rebound above Nasdaq minimum bid priceJanuary 16, 2025 | msn.comShould You Invest in Precigen (PGEN)?January 16, 2025 | msn.comPrecigen’s Strategic Advancements and Pipeline Developments Drive Buy RatingJanuary 14, 2025 | markets.businessinsider.comPrecigen (NASDAQ:PGEN) Receives Market Outperform Rating from JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $5.00 price target on shares of Precigen in a report on Tuesday.January 14, 2025 | marketbeat.comPrecigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 13, 2025 | prnewswire.comPrecigen to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | prnewswire.com Remove Ads Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.150.79▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼272▲PGEN Articles Average Week Remove Ads Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DNLI News Today ARWR News Today BLTE News Today ARQT News Today TARS News Today HRMY News Today JANX News Today TVTX News Today APGE News Today IRON News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHere’s Why Tesla Insiders are Dumping SharesTesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our res...Behind the Markets | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
